{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T09:37:24Z","timestamp":1793266644877,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","award":["GR-2018-12368352"],"award-info":[{"award-number":["GR-2018-12368352"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009647","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009647","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["835286"],"award-info":[{"award-number":["835286"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jpet.2026.105023","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T15:13:05Z","timestamp":1788016385000},"page":"105023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Capsaicin and cinnamaldehyde as topical transient receptor potential vanilloid 1 and transient receptor potential ankyrin 1 agonists in humans: Formulation, stability, and pharmacodynamic evaluation"],"prefix":"10.1016","volume":"393","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3598-0195","authenticated-orcid":false,"given":"Luigi Francesco","family":"Iannone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika Maria","family":"Mancuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Pasquini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Romozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Nassini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierangelo","family":"Geppetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice","family":"Petraglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"De Cesaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5481-6373","authenticated-orcid":false,"given":"Silvia","family":"Fiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natascia","family":"Mennini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8706-3925","authenticated-orcid":false,"given":"Viola","family":"Seravalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpet.2026.105023_bib1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/23328940.2022.2075218","article-title":"Neuronal and non-neuronal TRPA1 as therapeutic targets for pain and headache relief","volume":"10","author":"Iannone","year":"2023","journal-title":"Temperature (Austin)"},{"issue":"10","key":"10.1016\/j.jpet.2026.105023_bib2","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/s41583-022-00611-7","article-title":"TRP channels: a journey towards a molecular understanding of pain","volume":"23","author":"Rosenbaum","year":"2022","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"10.1016\/j.jpet.2026.105023_bib3","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1152\/physrev.00059.2021","article-title":"CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond","volume":"103","author":"Russo","year":"2023","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jpet.2026.105023_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1204734","article-title":"The vascular role of CGRP: a systematic review of human studies","volume":"14","author":"Al-Karagholi","year":"2023","journal-title":"Front Neurol"},{"key":"10.1016\/j.jpet.2026.105023_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136380","article-title":"The role of TRP ion channels in migraine and headache","volume":"768","author":"Iannone","year":"2022","journal-title":"Neurosci Lett"},{"issue":"12","key":"10.1016\/j.jpet.2026.105023_bib6","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nrneurol.2017.137","article-title":"Human models of migraine - short-term pain for long-term gain","volume":"13","author":"Ashina","year":"2017","journal-title":"Nat Rev Neurol"},{"issue":"12","key":"10.1016\/j.jpet.2026.105023_bib7","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.drudis.2018.06.020","article-title":"Human pharmacological approaches to TRP-ion-channel-based analgesic drug development","volume":"23","author":"Weyer-Menkhoff","year":"2018","journal-title":"Drug Discov Today"},{"issue":"20","key":"10.1016\/j.jpet.2026.105023_bib8","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1523\/JNEUROSCI.3048-18.2019","article-title":"A human TRPA1-specific pain model","volume":"39","author":"Heber","year":"2019","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpet.2026.105023_bib40","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/bcp.13143","article-title":"Development of an in vivo target-engagement biomarker for TRPA1 antagonists in humans","volume":"83","author":"Buntinx","year":"2017","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.jpet.2026.105023_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41573-021-00268-4","article-title":"Advances in TRP channel drug discovery: from target validation to clinical studies","volume":"21","author":"Koivisto","year":"2022","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"10.1016\/j.jpet.2026.105023_bib10","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1208\/s12249-010-9522-9","article-title":"Validation of a static Franz diffusion cell system for in vitro permeation studies","volume":"11","author":"Ng","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jpet.2026.105023_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2019.103965","article-title":"Laser speckle contrast imaging, the future DBF imaging technique for TRP target engagement biomarker assays","volume":"129","author":"Bamps","year":"2020","journal-title":"Microvasc Res"},{"issue":"10","key":"10.1016\/j.jpet.2026.105023_bib12","doi-asserted-by":"crossref","first-page":"8919","DOI":"10.3390\/molecules16108919","article-title":"Determination of capsaicin and dihydrocapsaicin in Capsicum fruit samples using high performance liquid chromatography","volume":"16","author":"Al Othman","year":"2011","journal-title":"Molecules"},{"issue":"1-2","key":"10.1016\/j.jpet.2026.105023_bib13","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ijpharm.2018.06.012","article-title":"Strat-M\u00ae synthetic membrane: permeability comparison to human cadaver skin","volume":"547","author":"Haq","year":"2018","journal-title":"Int J Pharm"},{"issue":"1-2","key":"10.1016\/j.jpet.2026.105023_bib14","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ijpharm.2016.11.013","article-title":"Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: effect of cyclodextrin complexation","volume":"515","author":"Mennini","year":"2016","journal-title":"Int J Pharm"},{"issue":"5","key":"10.1016\/j.jpet.2026.105023_bib15","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/bcp.12704","article-title":"Development of anti-migraine therapeutics using the capsaicin-induced dermal blood flow model","volume":"80","author":"Buntinx","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.jpet.2026.105023_bib17","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1177\/0333102413517773","article-title":"Development of an experimental model to study trigeminal nerve-mediated vasodilation on the human forehead","volume":"34","author":"Ibrahimi","year":"2014","journal-title":"Cephalalgia"},{"issue":"3","key":"10.1016\/j.jpet.2026.105023_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3390\/cosmetics8030069","article-title":"Towards optimal pH of the skin and topical formulations: from the current state of the art to tailored products","volume":"8","author":"Luki\u0107","year":"2021","journal-title":"Cosmetics"},{"issue":"10","key":"10.1016\/j.jpet.2026.105023_bib19","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3390\/ph15101279","article-title":"Development of capsaicin-containing analgesic silicone-based transdermal patches","volume":"15","author":"L\u00e1szl\u00f3","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"issue":"12","key":"10.1016\/j.jpet.2026.105023_bib20","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1177\/0333102416668659","article-title":"The influence of migraine and female hormones on capsaicin-induced dermal blood flow","volume":"37","author":"Ibrahimi","year":"2017","journal-title":"Cephalalgia"},{"key":"10.1016\/j.jpet.2026.105023_bib21","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1146\/annurev.physiol.68.040204.100431","article-title":"An introduction to TRP channels","volume":"68","author":"Ramsey","year":"2006","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.jpet.2026.105023_bib22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/164_2019_336","article-title":"Ion channel pharmacology for pain modulation","volume":"260","author":"De Logu","year":"2019","journal-title":"Handb Exp Pharmacol"},{"issue":"9","key":"10.1016\/j.jpet.2026.105023_bib23","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s13238-017-0395-5","article-title":"TRPV1 and TRPA1 in cutaneous neurogenic and chronic inflammation: pro-inflammatory response induced by their activation and their sensitization","volume":"8","author":"Gouin","year":"2017","journal-title":"Protein Cell"},{"issue":"11","key":"10.1016\/j.jpet.2026.105023_bib24","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.molmed.2006.09.001","article-title":"TRPV1: a therapeutic target for novel analgesic drugs?","volume":"12","author":"Szallasi","year":"2006","journal-title":"Trends Mol Med"},{"issue":"6","key":"10.1016\/j.jpet.2026.105023_bib25","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.cell.2006.02.023","article-title":"TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents","volume":"124","author":"Bautista","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.jpet.2026.105023_bib26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-physiol-030212-183811","article-title":"TRPA1: a gatekeeper for inflammation","volume":"75","author":"Bautista","year":"2013","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.jpet.2026.105023_bib27","series-title":"Neurobiology of TRP Channels","first-page":"125","article-title":"TRP channels and pain","author":"Gonzalez-Ramirez","year":"2017"},{"issue":"suppl 1","key":"10.1016\/j.jpet.2026.105023_bib28","article-title":"CGRP receptors and TRP channels in migraine","volume":"16","author":"Geppetti","year":"2015","journal-title":"J Headache Pain"},{"key":"10.1016\/j.jpet.2026.105023_bib29","series-title":"Neurogenic Inflammation","author":"Geppetti","year":"1996"},{"issue":"6852","key":"10.1016\/j.jpet.2026.105023_bib30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/35093019","article-title":"Molecular mechanisms of nociception","volume":"413","author":"Julius","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jpet.2026.105023_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-981-13-1756-9_2","article-title":"TRP channels in nociception and pathological pain","volume":"1099","author":"Hung","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jpet.2026.105023_bib32","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.jconrel.2023.12.008","article-title":"Assessment of antibiotic release and antibacterial efficacy from pendant glutathione hydrogels using ex vivo porcine skin","volume":"365","author":"Andrianopoulou","year":"2024","journal-title":"J Control Release"},{"issue":"6","key":"10.1016\/j.jpet.2026.105023_bib33","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.3390\/molecules26061650","article-title":"Effect of penetration enhancers on toenail delivery of efinaconazole from hydroalcoholic preparations","volume":"26","author":"Park","year":"2021","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.jpet.2026.105023_bib34","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.3390\/pharmaceutics14122567","article-title":"Development and characterization of cyclodextrin-based nanogels as a new ibuprofen cutaneous delivery system","volume":"14","author":"Cirri","year":"2022","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.jpet.2026.105023_bib35","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3390\/pharmaceutics10030148","article-title":"Franz diffusion cell approach for preformulation characterization of ketoprofen semi-solid dosage forms","volume":"10","author":"Salamanca","year":"2018","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.jpet.2026.105023_bib36","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ijpharm.2016.08.052","article-title":"Comparative evaluation of rivastigmine permeation from a transdermal system in the Franz cell using synthetic membranes and pig ear skin with in vivo-in vitro correlation","volume":"512","author":"Simon","year":"2016","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.jpet.2026.105023_bib37","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/pharmaceutics12020173","article-title":"Usefulness of artificial membrane, Strat-M\u00ae, in the assessment of drug permeation from complex vehicles in finite dose conditions","volume":"12","author":"Arce","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jpet.2026.105023_bib38","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejps.2014.11.002","article-title":"Prediction of skin permeation by chemical compounds using the artificial membrane, Strat-M","volume":"67","author":"Uchida","year":"2015","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"10.1016\/j.jpet.2026.105023_bib39","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1152\/jappl.1990.68.2.731","article-title":"Mechanism of ethanol-induced vasodilation","volume":"68","author":"Malpas","year":"1990","journal-title":"J Appl Physiol (1985)"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526012231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526012231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T09:19:35Z","timestamp":1793265575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526012231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0022356526012231"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.105023","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Capsaicin and cinnamaldehyde as topical transient receptor potential vanilloid 1 and transient receptor potential ankyrin 1 agonists in humans: Formulation, stability, and pharmacodynamic evaluation","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.105023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"105023"}}